Pluripotent stem cell-based cancer therapy: promise and challenges.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22461639.
- Also identified by DOI 10.1126/scitranslmed.3003920 and PMC identifier 3397797.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The development of induced pluripotent stem cell (iPSC) technology has generated enthusiasm about the therapeutic potential of these cells for treating a variety of diseases. However, the evidence that they actually will be clinically useful is limited. Here, we discuss the potential therapeutic applications of iPSCs for treating cancer and other diseases and highlight the current barriers restricting their use.
Medical subject headings
- Neoplasms
- Pluripotent Stem Cells
- Stem Cell Transplantation